Side-by-side comparison of AI visibility scores, market position, and capabilities
Tel Aviv/NYC data pipeline and orchestration platform; raised $50M+; unified ELT, reverse ETL, and workflow orchestration for cloud data warehouses.
Rivery is a data pipeline and orchestration platform founded in 2018 and headquartered in Tel Aviv, Israel, with offices in New York City. The company was founded by Itamar Ben Hemo and Or Lenchner to build a unified data operations platform that covers data ingestion, transformation, reverse ETL (data activation), and workflow orchestration in a single environment. Rather than requiring data teams to stitch together separate tools for each stage of the data lifecycle, Rivery provides an integrated platform where all data workflows — from source connection to downstream activation — are managed and monitored in one place.\n\nRivery raised $50 million in funding from investors including Salesforce Ventures, YL Ventures, and Entrée Capital. The platform supports ingestion from more than 200 sources, in-pipeline transformations, and native reverse ETL to sync data from warehouses back into operational tools like Salesforce, HubSpot, and customer data platforms. Its orchestration engine allows teams to build dependency graphs across pipelines, trigger workflows based on events or schedules, and monitor data flow health through a unified dashboard. Rivery's integrated approach reduces the operational overhead of managing multiple single-function tools that each require separate infrastructure, monitoring, and maintenance.\n\nRivery serves data teams at mid-market and enterprise companies across e-commerce, fintech, and media who need a flexible, cloud-native data operations platform without the deployment complexity of open-source tools. The platform runs fully managed in the cloud with Rivery handling all infrastructure, scaling, and maintenance. Its visual pipeline builder makes it accessible to data analysts and business intelligence developers without deep engineering backgrounds.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.